Sign in

CIK 0000886163

  • Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770160744
Phone
+1 858-550-7500
Business address
7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 4 Grant or award Director acquired 1,209 shares (grant or award)
  2. 4 Open-market sale CLO & Secretary sold 1,000 shares at $104.00 ($104,000)
  3. 4 Exercise or conversion Director acquired 2,406 shares (option exercise)
  4. 4 Open-market buy Chief Executive Officer bought 9,510 shares at an average $105.20 ($1,000,456)
  5. 4 Open-market buy Chief Financial Officer bought 1,500 shares at an average $104.06 ($156,090)
  6. 4 Exercise or conversion Director acquired 2,406 shares (option exercise)
  7. 4 Grant or award CLO & Secretary acquired 6,415 shares (grant or award)
  8. 4 Open-market sale Chief Financial Officer sold 5,000 shares at $115.03 ($575,149)
  9. 4 Grant or award Chief Executive Officer acquired 21,382 shares (grant or award)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 13,452 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 9,587 shares (to pay taxes)
  12. 4 Shares withheld for taxes CLO & Secretary gave up 6,523 shares (to pay taxes)
  13. 4 Open-market sale Chief Financial Officer sold 2,104 shares at $116.37 ($244,850)
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 1,859 shares (to pay taxes)
  15. 4 Open-market sale Director sold 2,406 shares at $123.65 ($297,502)
  16. 4 Open-market sale CLO & Secretary sold 2,000 shares at $99.60 ($199,201)
  17. 4 Open-market sale Chief Financial Officer sold 1,275 shares at an average $103.94 ($132,518)
  18. 4 Open-market sale President & COO sold 16,047 shares at an average $102.35 ($1,642,359)
  19. 4 Exercise or conversion Chief Financial Officer acquired 1,486 shares (option exercise)
  20. 4 Exercise or conversion President & COO acquired 5,774 shares (option exercise)

Page 5 of 51 · 1,001 filings